Prevalence and clinical characteristics of lower limb atherosclerotic lesions in newly diagnosed patients with ketosis-onset diabetes: A cross-sectional study

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Li, Mei Fang ^a   Ren, Ying ^a   Zhao, Cui Chun ^a   Zhang, Rong ^a   Li, Lian Xi ^a   Liu, Fang ^a   Lu, Jun Xi ^a   Tu, Yin Fang ^a   Zhao, Wei Jing ^a   Bao, Yu Qian ^a   Jia, Wei Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Atherosclerosis; Ketosis onset diabetes; Lower limb arteries; Type 1 diabetes; Type 2 diabetes

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHINESE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEEP FEMORAL ARTERY; DIABETIC KETOACIDOSIS; DIABETIC PATIENT; FEMALE; FEMORAL ARTERY; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPLITEAL ARTERY; PRIORITY JOURNAL; RISK FACTOR; SUPERFICIAL FEMORAL ARTERY; TIBIAL ARTERY;

EID: 84902536913     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-71     Document Type: Article

References (58)

1. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Alberti KG, Zimmet PZ, Diabet Med 1998 15 7 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0. CO;2-S 9686693 (Pubitemid 28319935)
2. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care 1997 20 7 1183 9203460
3. Intermittent need for insulin in a subgroup of diabetic patients in Tanzania. Ahren B, Corrigan CB, Diabet Med 1985 2 4 262 264 2951079 (Pubitemid 15246125)
4. Diabetic ketoacidosis in obese African-Americans. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS, Diabetes 1995 44 7 790 795 10.2337/diab.44.7.790 7789647
5. PAX4 gene variations predispose to ketosis-prone diabetes. Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M, Riveline JP, Rajan AS, Kevorkian JP, Zhang S, Vexiau P, German MS, Vaisse C, Hum Mol Genet 2004 13 24 3151 3159 10.1093/hmg/ddh341 15509590 (Pubitemid 40045267)
6. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity. Balasubramanyam A, Zern JW, Hyman DJ, Pavlik V, Arch Intern Med 1999 159 19 2317 2322 10547172 (Pubitemid 29501532)
7. Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes duration. Ramos-Roman MA, Pinero-Pilona A, Adams-Huet B, Raskin P, J Diabetes Complications 2006 20 3 137 144 10.1016/j.jdiacomp.2006.01. 005 16632232
8. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, Charpentier G, Guillausseau PJ, Vexiau P, Gautier JF, Diabetes 2004 53 3 645 653 10.2337/diabetes.53.3.645 14988248 (Pubitemid 38270633)
9. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, Nepom GT, Clark WS, Mixon PS, Kitabchi AE, Diabetes Care 1999 22 9 1517 1523 10.2337/diacare.22.9.1517 10480519 (Pubitemid 29418249)
10. Prevalence and clinical characteristics of carotid atherosclerosis in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study. Li LX, Zhao CC, Ren Y, Tu YF, Lu JX, Wu X, Zhang WX, Zhu JA, Li MF, Yu LB, Bao YQ, Jia WP, Cardiovasc Diabetol 2013 12 18 10.1186/1475-2840-12-18 23324539
11. Childhood diabetes in China. Enormous variation by place and ethnic group. Yang Z, Wang K, Li T, Sun W, Li Y, Chang YF, Dorman JS, LaPorte RE, Diabetes Care 1998 21 4 525 529 10.2337/diacare.21.4.525 9571336 (Pubitemid 28172928)
12. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Zhou Z, Xiang Y, Ji L, Jia W, Ning G, Huang G, Yang L, Lin J, Liu Z, Hagopian WA, Leslie RD, LADA China Study Group, Diabetes 2013 62 2 543 550 10.2337/db12-0207 23086039
13. Autoantibodies in diabetes. Pihoker C, Gilliam LK, Hampe CS, Lernmark A, Diabetes 2005 54 Suppl 2 52 S61 16306341
14. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Yang L, Luo S, Huang G, Peng J, Li X, Yan X, Lin J, Wenzlau JM, Davidson HW, Hutton JC, Zhou Z, Diabetes Metab Res Rev 2010 26 7 579 584 10.1002/dmrr.1128 20842762
15. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Hawa MI, Fava D, Medici F, Deng YJ, Notkins AL, De Mattia G, Leslie RD, Diabetes Care 2000 23 2 228 233 10.2337/diacare.23.2.228 10868836 (Pubitemid 30071029)
16. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients. Pardini VC, Mourao DM, Nascimento PD, Vivolo MA, Ferreira SR, Pardini H, Braz J Med Biol Res 1999 32 10 1195 1198 10.1590/S0100-879X1999001000003 10510254 (Pubitemid 129546650)
17. Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin-dependent diabetes mellitus. Ohta M, Obayashi H, Takahashi K, Kitagawa Y, Nakano K, Matsuo S, Nishimura M, Itoh N, Ohta K, Clin Chem 1996 42 12 1975 1978 8969635 (Pubitemid 26415348)
18. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H, Diabetologia 2001 44 Suppl 2 14 S21 11587045
19. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Scholte AJ, Schuijf JD, Kharagjitsingh AV, Jukema JW, Pundziute G, van der Wall EE, Bax JJ, Heart 2008 94 3 290 295 10.1136/hrt.2007.121921 17646190 (Pubitemid 351303418)
20. The changing natural history of nephropathy in type I diabetes. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR, Am J Med 1985 78 5 785 794 10.1016/0002-9343(85)90284-0 3993659 (Pubitemid 15008233)
21. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T, Diabetologia 1983 25 6 496 501 6363177 (Pubitemid 14200886)
22. Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: association with time of onset and diabetic state. Licata G, Tuttolomondo A, Corrao S, Di Raimondo D, Fernandez P, Caruso C, Avellone G, Pinto A, Int J Immunopathol Pharmacol 2006 19 3 639 646 17026849 (Pubitemid 44580537)
23. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Tuttolomondo A, Pinto A, Salemi G, Di Raimondo D, Di Sciacca R, Fernandez P, Ragonese P, Savettieri G, Licata G, Nutr Metab Cardiovasc Dis 2008 18 2 152 157 10.1016/j.numecd.2007.02.003 17702553 (Pubitemid 351282470)
24. The combination of carotid and lower extremity ultrasonography increases the detection of atherosclerosis in type 2 diabetes patients. Li L, Yu H, Zhu J, Wu X, Liu F, Zhang F, Li Q, Wu S, Bao Y, Jia W, J Diabetes Complications 2012 26 1 23 28 10.1016/j.jdiacomp.2011.11.006 22226486
25. Retinal microvascular abnormalities are associated with early carotid atherosclerotic lesions in hospitalized Chinese patients with type 2 diabetes mellitus. Li LX, Li MF, Lu JX, Jia LL, Zhang R, Zhao CC, Ren Y, Tu YF, Shen Y, Liu F, Bao YQ, Jia WP, J Diabetes Complications 2014 28 3 378 385 10.1016/j.jdiacomp.2014.02.004 24656691
26. Body mass index as an indicator of obesity. Weisell RC, Asia Pac J Clin Nutr 2002 11 Suppl 8 681 S684 12534690
27. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2002 39 2 Suppl 1 1 S266 11904577
28. Comparison of carotid and lower limb atherosclerotic lesions in both previously known and newly diagnosed type 2 diabetes mellitus. Li LX, Wu X, Lu JX, Tu YF, Yu LB, Li MF, Zhang WX, Zhu JA, Yuan GY, Bao YQ, Jia WP, J Diabetes Investig 2014 http://www.onlinelibrary.wiley.com/doi/10.1111/jdi.12204/full
29. Mannheim intima-media thickness consensus. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F, Advisory Board of the 3rd Watching the Risk Symposium 2004, 13th European Stroke Conference, Cerebrovasc Dis 2004 18 4 346 349 10.1159/000081812 15523176 (Pubitemid 39664263)
30. Peripheral arterial Doppler ultrasonography: diagnostic criteria. Sacks D, Robinson ML, Marinelli DL, Perlmutter GS, J Ultrasound Med 1992 11 3 95 103 1608083 (Pubitemid 23061971)
31. Accuracy of lower extremity arterial duplex mapping. Moneta GL, Yeager RA, Antonovic R, Hall LD, Caster JD, Cummings CA, Porter JM, J Vasc Surg 1992 15 2 275 283 discussion 283-274 10.1016/0741-5214(92)90249-8 1735888
32. Low-grade albuminuria is associated with early but not late carotid atherosclerotic lesions in community-based patients with type 2 diabetes. Li MF, Tu YF, Li LX, Lu JX, Dong XH, Yu LB, Zhang R, Bao YQ, Jia WP, Hu RM, Cardiovasc Diabetol 2013 12 1 110 10.1186/1475-2840-12-110 23883448
33. Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus. Smiley D, Chandra P, Umpierrez GE, Diabetes Manag (Lond) 2011 1 6 589 600 10.2217/dmt.11.57 22611441
34. Improved glycemic control in subjects with atypical diabetes results from restored insulin secretion, but not improved insulin sensitivity. Rasouli N, Elbein SC, J Clin Endocrinol Metab 2004 89 12 6331 6335 10.1210/jc.2004-1016 15579799 (Pubitemid 39628455)
35. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission. Gosmanov AR, Smiley D, Robalino G, Siqueira JM, Peng L, Kitabchi AE, Umpierrez GE, Diabetes Care 2010 33 4 854 860 10.2337/dc09-1687 20067967
36. Pathophysiology of ketoacidosis in Type 2 diabetes mellitus. Linfoot P, Bergstrom C, Ipp E, Diabet Med 2005 22 10 1414 1419 10.1111/j.1464-5491.2005. 01660.x 16176205 (Pubitemid 41391320)
37. Ketosis-prone type 2 diabetes: effect of hyperglycemia on beta-cell function and skeletal muscle insulin signaling. Umpierrez GE, Smiley D, Gosmanov A, Thomason D, Endocr Pract 2007 13 3 283 290 10.4158/EP.13.3.283 17599861
38. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Evans JL, Goldfine ID, Maddux BA, Grodsky GM, Diabetes 2003 52 1 1 8 10.2337/diabetes.52.1.1 12502486 (Pubitemid 36042100)
39. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. Sobngwi E, Gautier JF, Kevorkian JP, Villette JM, Riveline JP, Zhang S, Vexiau P, Leal SM, Vaisse C, Mauvais-Jarvis F, J Clin Endocrinol Metab 2005 90 8 4446 4451 10.1210/jc.2004-2545 15914531 (Pubitemid 41159325)
40. Do hypertension and diabetes mellitus influence the site of atherosclerotic plaques? Danese C, Vestri AR, D'Alfonso V, Deriu G, Dispensa S, Baldini R, Ambrosino M, Colotto M, Clin Ter 2006 157 1 9 13 16669546 (Pubitemid 44898226)
41. Blood pressure and atherosclerotic plaques in carotid, aortic and femoral arteries in elderly Finns with diabetes mellitus or impaired glucose tolerance. Rajala U, Laakso M, Paivansalo M, Suramo I, Keinanen-Kiukaanniemi S, J Hum Hypertens 2005 19 1 85 91 10.1038/sj.jhh.1001779 15343356 (Pubitemid 40163972)
42. Atherosclerotic lesions are more frequent in femoral arteries than in carotid arteries independent of increasing number of risk factors. Kroger K, Kucharczik A, Hirche H, Rudofsky G, Angiology 1999 50 8 649 654 10.1177/000331979905000805 10451232 (Pubitemid 29372979)
43. Echographic assessment of carotid and femoral arterial structure in men with essential hypertension. Group PCVMETRA. Gariepy J, Simon A, Massonneau M, Linhart A, Segond P, Levenson J, Am J Hypertens 1996 9 2 126 136 10.1016/0895-7061(95)00262-6 8924262 (Pubitemid 26108113)
44. Femoral atherosclerosis in an older British population: prevalence and risk factors. Leng GC, Papacosta O, Whincup P, Wannamethee G, Walker M, Ebrahim S, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD, Atherosclerosis 2000 152 1 167 174 10.1016/S0021-9150(99)00447-5 10996352
45. Ultrasound-assessed plaque occurrence in the carotid and femoral arteries are independent predictors of cardiovascular events in middle-aged men during 10 years of follow-up. Davidsson L, Fagerberg B, Bergstrom G, Schmidt C, Atherosclerosis 2010 209 2 469 473 10.1016/j.atherosclerosis.2009.10.016 19897198
46. Prevalence and distribution of sub-clinical atherosclerosis by screening vascular ultrasound in low and intermediate risk adults: the New York physicians study. Postley JE, Perez A, Wong ND, Gardin JM, J Am Soc Echocardiogr 2009 22 10 1145 1151 10.1016/j.echo.2009.07.010 19801304
47. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Schmidt C, Fagerberg B, Hulthe J, Atherosclerosis 2005 181 1 125 130 10.1016/j. atherosclerosis.2004.12.034 15939063 (Pubitemid 40804702)
48. Comparative histological study of atherosclerotic lesions and microvascular changes in amputated lower limbs of diabetic and non-diabetic patients. Santos VP, Caffaro RA, Pozzan G, Saieg MA, Castelli Junior V, Arq Bras Endocrinol Metabol 2008 52 7 1115 1123 10.1590/S0004-27302008000700007 19082299
49. Large and small artery occlusion in diabetics and nondiabetics with severe vascular disease. Conrad MC, Circulation 1967 36 1 83 91 10.1161/01.CIR.36.1.83 6027218
50. Peripheral arterial disease in people with diabetes. American Diabetes Association, Diabetes Care 2003 26 12 3333 3341 14633825
51. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Tseng CH, Angiology 2003 54 3 331 338 10.1177/000331970305400309 12785026
52. The Interrelation between carotid, femoral and coronary artery disease. Rothwell PM, Eur Heart J 2001 22 1 11 14 10.1053/euhj.2000.2226 11133203 (Pubitemid 32622182)
53. Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness. Kogawa K, Nishizawa Y, Hosoi M, Kawagishi T, Maekawa K, Shoji T, Okuno Y, Morii H, Diabetes 1997 46 4 682 687 10.2337/diab.46.4.682 9075811 (Pubitemid 27143387)
54. Correlation of femoral intima-media thickness and the severity of coronary artery disease. Kirhmajer MV, Banfic L, Vojkovic M, Strozzi M, Bulum J, Miovski Z, Angiology 2011 62 2 134 139 10.1177/0003319710375087 20705617
55. Framingham risk score is associated with femoral artery intima-media thickness in asymptomatic young adults (the Bogalusa heart study). Paul TK, Chen W, Srinivasan SR, Rice J, Toprak A, He J, Berenson GS, Atherosclerosis 2010 213 2 627 631 10.1016/j.atherosclerosis.2010.09.026 20970137
56. Femoral rather than carotid artery ultrasound imaging predicts extent and severity of coronary artery disease. Sosnowski C, Pasierski T, Janeczko-Sosnowska E, Szulczyk A, Dabrowski R, Wozniak J, Suminski A, Ruzyllo W, Kardiol Pol 2007 65 7 760 766 discussion 767-768 17694457 (Pubitemid 47358788)
57. Intima-media thickness is a useful marker of the extent of coronary artery disease in patients with impaired renal function. Lisowska A, Musial WJ, Lisowski P, Knapp M, Malyszko J, Dobrzycki S, Atherosclerosis 2009 202 2 470 475 10.1016/j.atherosclerosis.2008.05.051 18621374
58. The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity? Pietropaolo M, Barinas-Mitchell E, Kuller LH, Diabetes 2007 56 5 1189 1197 10.2337/db06-0880 17322478 (Pubitemid 46722429)